(Phys.org) —Researchers at Temple University and the University of Delaware have published a study in the Journal of Biological Chemistry that sheds new light on the clotting effects of a drug that is being tested as a potential treatment for hemophilia.
Referred to as the "royal disease" for its presence in Europe's royal families in the 19th and 20th centuries, a genetic legacy traced to Queen Victoria, hemophilia is a rare disorder in which the blood's ability to clot is impaired. The disease, which most often is transmitted genetically from carrier mothers to their sons, affects one in every 5,000 males born today, according to the National Institutes of Health. It also may occur in women, although much more rarely.
The incidence is much higher in males because a critical gene for blood clotting is carried on the X chromosome. Males have only one X chromosome, so if it is defective for the gene, they will inherit hemophilia. Since females have two X chromosomes, if one is defective for the clotting gene, the other chromosome can compensate.
Under normal circumstances, when a blood vessel is cut, platelets arrive in seconds and begin sticking together to stop the bleeding. The surface of the platelets supports other proteins called "clotting factors," which bind with the platelets to form a tight clot. Thirteen clotting factors are known and are named by Roman numerals, from Factor I to Factor XIII.
"When a blood vessel is injured in a person with hemophilia, the platelets, the 'policemen' that are the first to respond, are fine, but some of the clotting factors are either missing or mutated," explains Ulhas Naik, professor of biological sciences at UD and a co-author of the study. "Without these clotting factors, the platelets can still form a plug to stop the bleeding, but it takes longer to build and is not as strong."
In their recent study, Naik, who directs the Delaware Cardiovascular Research Center based at UD, and Satya Kunapuli, director of Temple's Sol Sherry Thrombosis Research Center, wanted to determine how the drug Fucoidan affects blood platelets. This drug, a sulfated polysaccharide, a type of carbohydrate derived from the brown seaweed Fucus vesiculosis, has shown promise in decreasing bleeding and clotting time for people with hemophilia and is now in clinical trials.
Through their laboratory experiments using a mouse model, and with the aid of colleague Steve Watson, professor and head of the Platelet Group at the University of Birmingham in the United Kingdom, the scientists confirmed that Fucoidan works by activating platelets versus replacing or amping up a specific clotting factor.
The researchers discovered the receptor on the platelets to which the drug binds, known as C-type lectin-like receptor 2 (CLEC-2), as well as its signaling pathway. They also found that snake venom activates this receptor. A bite from a venomous snake enlists platelets to form blood clots, which help incapacitate its prey.
"Fucoidan enhances blood clotting in people with hemophilia, but in a normal person, this could be a problem," Naik says. "Thus, it's important in clinical trials that this drug not be given to control subjects because, for them, it may cause unwanted platelet activation and, thus, clot formation."
Naik and Kunapuli have been collaborating on cardiovascular studies for the last few years, making reciprocal laboratory visits, phone and Skype calls to monitor progress and to discuss new research ideas. In this latest study, Kunapuli's team at Temple, especially graduate student Bhanu Kumar Manne, conducted most of the laboratory experiments, and Naik at UD contributed to the analysis and interpretation of the research findings.
Today, more than 400,000 people worldwide are estimated to have hemophilia.
World Hemophilia Day is April 17. The event, held each year on that day, is designed to increase awareness of hemophilia and other inherited bleeding disorders.
Explore further: Researchers discover that JAM-A protein keeps blood clots in check
More information: www.jbc.org/content/288/11/7717.abstract
8 hours ago Hi guys, I'm having a bit of difficulty understanding Pourboix diagrams. The biggest problem at the moment is that I don't clearly understand what... 9 hours ago Hi to all, I want to know the temperature after combustion of methane with air. How will i calculate it? Kindly inform me. Regards,... Apr 28, 2013 I am familiar with the equation ?G=?G°+RT ln(Q).But I can't derive it.We have to use the equation to derive nernst equation. So please help. Apr 28, 2013 Hi, can someone please explain to me how I can identify which is the oxidation half and which is the reduction half of a redox reaction. I have read... Apr 27, 2013 I have been urinating into a plastic bottle lately (I will not elaborate why), and have been finding the bottle to hold a vacuum the following... Apr 27, 2013 Can someone outline a comprehensive way to figure out and write all the different isomers of square planar and octahedral single-centre coordination... Oct 23, 2011 A genetically engineered clotting factor that controlled hemophilia in an animal study offers a novel potential treatment for human hemophilia and a broad range of other bleeding problems.
May 03, 2012 those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.
Nov 20, 2012 New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves ...
Nov 02, 2011 An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events ...
4 hours ago (Phys.org) —While the natural world is replete with compounds that form the basis of many disease-fighting pharmaceuticals, it is also the case that humans and other mammals produce their own host-defense ...
9 hours ago (Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause ...
Apr 29, 2013 (Phys.org) —A combined team of researchers from the U.S. and Slovenia has succeeded in creating "origami" type proteins that assemble themselves into three dimensional shapes. As a proof of concept, the ...
Apr 25, 2013 (Phys.org) —Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new ...
(Phys.org) —While the natural world is replete with compounds that form the basis of many disease-fighting pharmaceuticals, it is also the case that humans and other mammals produce their own host-defense ...
(Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause ...
From methanol to formaldehyde - this reaction is the starting point for the synthesis of many everyday plastics. Using catalysts made of gold particles, formaldehyde could be produced without the environmentally ...
Researchers have found that reusing the by-products of fruit and cereal processing could help promote the sustainability of the food industry, as long as its overall environmental fingerprint is clearly evaluated.
(Phys.org) —A combined team of researchers from the U.S. and Slovenia has succeeded in creating "origami" type proteins that assemble themselves into three dimensional shapes. As a proof of concept, the ...
Although eleventh-century Vikings did not have magnetic compasses at their disposal, it is thought that they could determine their orientation at sea using sun-compasses. Sun-compasses use the position of ...
The atoms that make up ordinary matter fall down, so do antimatter atoms fall up? Do they experience gravity the same way as ordinary atoms, or is there such a thing as antigravity?
Pick up your smartphone. How are financial markets faring? Check Dow Jones or the S&P 500. Average temperature in the United State last July 4th? Steer your iPad over to the National Weather Service. OK, ...
A quantum computer is controlled by the laws of quantum physics; it promises to perform complicated calculations, or search large amounts of data, at a speed that exceeds by far those that today's fastest supercomputers are ...
(Phys.org) —As planets age they become darker and cooler. Saturn however is much brighter than expected for a planet of its age - a question that has puzzled scientists since the late sixties. New research ...
© Phys.org™ 2003-2013var _comscore = _comscore || [];var csDocDomain = document.location.href; _comscore.push({ c1: "2", c2: "6035753", c3: "6035753", c4: csDocDomain }); (function() { var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true; s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js"; el.parentNode.insertBefore(s, el);})();
No comments:
Post a Comment